{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:14:24Z","timestamp":1792678464240,"version":"4.5.0"},"reference-count":25,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: This study aimed to improve the knowledge of seizures and epilepsy in children with neurofibromatosis type 1 (NF1) by evaluating the frequency, clinical characteristics, and risk for epilepsy in children with NF1. Methods: The retrospective study included all NF1 patients aged one month to 18 years treated at the Institute from 2010 to 2025, who experienced seizures. Diagnosis of NF1 was made using revised diagnostic criteria from 2021. The seizures were classified according to the ILAE classification, updated in 2025. Further parameters were analyzed: sex, age at seizure onset, type and duration, electroencephalographic (EEG) findings, brain magnetic-resonance imaging (MRI), anti-seizure medications (ASMs), treatment response, and outcome. The patients were divided into two groups: epilepsy\u2014NF1 patients (14) and non-epilepsy\u2014NF1 patients (104). To evaluate the predictive factors for epilepsy in NF1 patients, univariate and multivariate logistic regression analyses were performed. Results: The study included 118 children with NF1. In 14 children (11.9%), a diagnosis of epilepsy was established. Ten of 14 children (71.4%) experienced SE. Good seizure control was achieved in 13\/14. We found statistically significant predictive values of hydrocephalus (p = 0.001), brain atrophy (p = 0.002), and vasculopathy (p = 0.015) for epilepsy in children with NF1. Conclusions: In our cohort, the frequency of epilepsy in NF children was at least ten times higher than in the general population. The predictive factors for epilepsy were hydrocephalus, brain atrophy, and vasculopathy. Recommendations for rescue medication and parental education are important, since status epilepticus occurs in a high percentage of NF1 patients with epilepsy.<\/jats:p>","DOI":"10.3390\/diagnostics15212690","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:31:58Z","timestamp":1761550318000},"page":"2690","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Characteristics of Seizures and Course of Epilepsy in Children with Neurofibromatosis Type 1\u2014A Tertiary Center Experience in a Cohort of 118 Children"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5481-9754","authenticated-orcid":false,"given":"Ru\u017eica","family":"Kravljanac","sequence":"first","affiliation":[{"name":"Institute for Mother and Child Healthcare of Serbia, 11070 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovana","family":"Be\u0111ik","sequence":"additional","affiliation":[{"name":"Institute for Mother and Child Healthcare of Serbia, 11070 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bruno","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health, IRCCS, Burlo Garofolo, 34137 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Vu\u010deti\u0107 Tadi\u0107","sequence":"additional","affiliation":[{"name":"Institute for Mother and Child Healthcare of Serbia, 11070 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofija","family":"Popovi\u0107","sequence":"additional","affiliation":[{"name":"Institute for Mother and Child Healthcare of Serbia, 11070 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Oparnica","sequence":"additional","affiliation":[{"name":"Institute for Mother and Child Healthcare of Serbia, 11070 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7621-0601","authenticated-orcid":false,"given":"Pavle","family":"Kravljanac","sequence":"additional","affiliation":[{"name":"Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jmg.35.10.813","article-title":"Neurofibromatosis type 1 (NF1): A protein truncation assay yielding identification of mutations in 73% of patients","volume":"35","author":"Park","year":"1998","journal-title":"J. Med. Genet."},{"key":"ref_2","first-page":"671","article-title":"Care of adults with neurofibromatosis type 1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Stewart","year":"2018","journal-title":"Genet. Med. J. Am. Coll. Med. Genet."},{"key":"ref_3","first-page":"1082","article-title":"Prevalence of neurofibromatosis type 1 in the finnish population","volume":"20","author":"Uusitalo","year":"2018","journal-title":"Genet. Med. J. Am. Coll. Med. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: An international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med."},{"key":"ref_5","first-page":"325","article-title":"Neurological manifestations of neurofibromatosis type 1: Our experience","volume":"37","year":"2022","journal-title":"Neurologia (Engl. Ed.)"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sorrentino, U., Bellonzi, S., Mozzato, C., Brasson, V., Toldo, I., Parrozzani, R., Clementi, M., Cassina, M., and Trevisson, E. (2021). Epilepsy in NF1: Epidemiologic, Genetic, and Clinical Features. A Monocentric Retrospective Study in a Cohort of 784 Patients. Cancers, 13.","DOI":"10.3390\/cancers13246336"},{"key":"ref_7","first-page":"e37385","article-title":"Phenotype and genotype of Saudi pediatric patients with neurofibromatosis type 1: A seven-year multicenter experience from Saudi Arabia","volume":"15","author":"Alfurayh","year":"2023","journal-title":"Cureus"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.17712\/nsj.2020.5.20200081","article-title":"Clinical spectrum of neurofibromatosis type 1 among children in a tertiary care center","volume":"25","author":"Bashiri","year":"2020","journal-title":"Neurosciences"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ped.13388","article-title":"Neurological comorbidity in children with neurofibromatosis type 1","volume":"60","author":"Hirabaru","year":"2018","journal-title":"Pediatr. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/epi.12348","article-title":"Epilepsy in individuals with neurofibromatosis type 1","volume":"54","author":"Ostendorf","year":"2013","journal-title":"Epilepsia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2329048X221131445","article-title":"Epilepsy and electroencephalogram characteristics in children with neurofibromatosis type 1, what we have learned from a tertiary center five years\u2019 experience","volume":"9","author":"Khair","year":"2022","journal-title":"Child Neurol. Open"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: A practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2014Report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the international league against epilepsy: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/epi.18338","article-title":"Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy","volume":"66","author":"Beniczky","year":"2025","journal-title":"Epilepsia"},{"key":"ref_16","first-page":"371","article-title":"The ten twenty electrode system of the International Federation","volume":"10","author":"Jasper","year":"1958","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1111\/ane.12186","article-title":"How long shall we record electroencephalography?","volume":"129","author":"Craciun","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.seizure.2015.06.003","article-title":"Diagnostic yield of five minutes compared to three minutes hyperventilation during electroencephalography","volume":"30","author":"Craciun","year":"2015","journal-title":"Seizure"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13052-018-0477-x","article-title":"Seizures in children with neurofibromatosis type 1: Is neurofibromatosis type 1 enough?","volume":"44","author":"Santoro","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1528-1157.1993.tb00452.x","article-title":"Neurofibromatosis Type One and West Syndrome: A Relatively Benign Association","volume":"34","author":"Motte","year":"1993","journal-title":"Epilepsia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/08830738030180050501","article-title":"Epilepsy in Neurofibromatosis 1","volume":"18","author":"Vivarelli","year":"2003","journal-title":"J. Child Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.yebeh.2017.05.011","article-title":"Epilepsy in Neurofibromatosis Type 1","volume":"73","author":"Pecoraro","year":"2017","journal-title":"Epilepsy Behav."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.seizure.2011.04.016","article-title":"Epileptic Seizures in Neurofibromatosis Type 1 Are Related to Intracranial Tumors but Not to Neurofibromatosis Bright Objects","volume":"20","author":"Hsieh","year":"2011","journal-title":"Seizure"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.yebeh.2019.06.022","article-title":"Epilepsy in Neurofibromatosis Type 1: Diffuse Cerebral Dysfunction?","volume":"98","author":"Serdaroglu","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_25","unstructured":"Kravljanac, R., Vucetic Tadic, B., Kravljanac, D., and Bedjik, J. (2024, January 20\u201325). Clinical characteristics of Seizures and Course of Epilepsy in Children with Neurofibromatosis type 1\u2014A Tertirary Center Experience. Proceedings of the 2024 Global NF Conference, Brussels, Belgium."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/21\/2690\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:43:41Z","timestamp":1761551021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/21\/2690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":25,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["diagnostics15212690"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15212690","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}